Pharmaceutical companies in the United States by P/S ratio

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

Viatris has the lowest figure of the 34 pharmaceutical companies in the United States ranked by P/S ratio, at 1.6, followed by Amneal Pharmaceuticals (2.5) and Bristol-Myers Squibb (2.5). Figures as of 19 Nov 2026, 19:31 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
34
Lowest
Viatris1.6
Median
7.9
Combined market value
$3.75T
Countries
1
Not ranked
10no P/S ratio on file

Market values as of .

United States
All sectors
Pharmaceuticals
USD
Clear filters
Pharmaceutical companies in the United States by P/S ratio
#CompanyP/S ↑Market capPriceToday1 yearPrice, 30 daysCountry
1ViatrisVTRS · Health Care1.6$22.9B$19.98 1.50% down 99% up United States
2Amneal PharmaceuticalsAMRX · Health Care2.5$7.4B$21.36 2.40% down 90% up United States
3Bristol-Myers SquibbBMY · Health Care2.5$119.6B$58.53 1.74% down 30% up United States
4PfizerPFE · Health Care2.5$157.7B$27.67 1.41% down 15% up United States
5Elanco Animal HealthELAN · Health Care2.8$13.3B$26.64 0.24% down 26% up United States
6PTC TherapeuticsPTCT · Health Care2.9$5B$59.36 1.44% down 21% down United States
7Legend BiotechLEGN · Health Care3.0$3.1B$16.04 1.29% down 41% down United States
8ZoetisZTS · Health Care3.5$33.4B$82.27 3.86% down 26% down United States
9BioMarin PharmaceuticalBMRN · Health Care3.7$12B$62.14 1.15% up 17% up United States
10Abbott LaboratoriesABT · Health Care4.1$180.3B$104.11 0.36% down 16% down United States
11Ionis PharmaceuticalsIONS · Health Care4.8$4.5B$26.96 1.59% down 63% down United States
12Merck & CoMRK · Health Care5.0$327B$132.64 3.73% down 45% up United States
13Alnylam PharmaceuticalsALNY · Health Care5.4$20.1B$149.83 0.29% up 66% down United States
14Regeneron PharmaceuticalsREGN · Health Care6.7$96.4B$931.84 1.45% down 28% up United States
15Johnson & JohnsonJNJ · Health Care6.8$642.3B$266.82 2.16% down 34% up United States
16Arrowhead PharmaceuticalsARWR · Health Care7.4$6.2B$43.62 1.17% up 13% up United States
17United TherapeuticsUTHR · Health Care7.5$24B$563.89 2.33% down 22% up United States
18AbbVieABBV · Health Care8.2$501.3B$283.60 0.84% down 25% up United States
19Corcept TherapeuticsCORT · Health Care9.4$7.2B$65.45 3.45% down 10% down United States
20Travere TherapeuticsTVTX · Health Care9.5$4.7B$48.77 2.93% down 45% up United States
21Madrigal PharmaceuticalsMDGL · Health Care9.6$9.2B$397.54 0.14% down 27% down United States
22Vertex PharmaceuticalsVRTX · Health Care11.0$132.5B$522.69 2.57% down 27% up United States
23Axsome TherapeuticsAXSM · Health Care11.1$7.1B$135.24 0.93% up 6% down United States
24Mirum PharmaceuticalsMIRM · Health Care12.0$6.3B$95.83 3.61% up 34% up United States
25TG TherapeuticsTGTX · Health Care16.0$9.9B$65.29 1.26% down 117% up United States
26Royalty PharmaRPRX · Health Care16.4$39.1B$67.98 1.00% down 79% up United States
27Eli LillyLLY · Health Care18.5$1.21T$1,356.48 1.90% down 33% up United States
28Ligand PharmaceuticalsLGND · Health Care21.7$5.8B$290.35 2.80% down 50% up United States
29BridgeBio PharmaBBIO · Health Care30.4$15.3B$78.43 0.54% up 21% up United States
30Rhythm PharmaceuticalsRYTM · Health Care42.8$8.1B$117.04 1.68% down 18% up United States
31InsmedINSM · Health Care52.4$31.7B$144.72 20.80% up 40% down United States
32CytokineticsCYTK · Health Care81.6$7.2B$51.58 0.51% up 19% down United States
33Protagonist TherapeuticsPTGX · Health Care178$8.2B$125.15 1.58% down 51% up United States
34Dianthus TherapeuticsDNTH · Health Care2389$4.9B$86.39 2.86% up 108% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. 10 companies have no P/S ratio on file and are not ranked here.

Questions and answers

Which pharmaceutical companies in the United States have the lowest P/S ratio?

Viatris (1.6), Amneal Pharmaceuticals (2.5) and Bristol-Myers Squibb (2.5) have the lowest P/S ratio of the 34 pharmaceutical companies in the United States ranked here as of 19 Nov 2026, 19:31 UTC.

How many pharmaceutical companies in the United States are in this ranking?

34 are ranked by P/S ratio. 10 more have no P/S ratio on file and are left out rather than ranked at zero.

What are these pharmaceutical companies in the United States worth together?

The 34 pharmaceutical companies in the United States ranked by P/S ratio have a combined market value of $3.75T as of 19 Nov 2026, 19:31 UTC.

What does ranking by P/S ratio measure?

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

Cite this page

Funkfolio, “Pharmaceutical companies in the United States by P/S ratio”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=ps-ratio

Underlying data: Yahoo Finance; SEC EDGAR.